A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
Recruiting · NCT07581951 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 3 | 2026-09-23 | NCT07581951 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haisco Pharmaceutical Group Co., Ltd. | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tsinghua Changgung Hospital | Beijing | China | 1 |